-+ 0.00%
-+ 0.00%
-+ 0.00%

Evotec 2025 Outlook: Revenues To Grow 5%-10%, Reaching €840M-€880M (Vs. €879.457M Est.), Sees Adj. EBITDA Of €30M-€50M; For 2028 Outlook, Expects 8%-12% CAGR And An EBITDA Margin Above 20%

Benzinga·04/17/2025 06:28:01
Listen to the news

Guidance for full-year 2025

Group revenues expected in the range of € 840 - 880 m (2024: € 797.0 m)

R&D expenditures are expected in a range of € 40 - 50 m (2024: € 50.8 m)

Adjusted Group EBITDA is expected to reach € 30 - 50 m (2024: € 22.6 m)

Outlook 2028

Group revenues CAGR 2024-2028 targeted to be in a range of 8 - 12 %

Adj. EBITDA margin 2028 expected to be above 20 %